SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post 177 Lu-DOTATATE and 177 Lu-PSMA617 setting.

Hong SongValentina FerriHeying DuanCarina Mari ApariciGuido DavidzonBenjamin L FrancFarshad MoradiJudy NguyenJagruti ShahAndrei H Iagaru

Published in: European journal of nuclear medicine and molecular imaging (2023)

Fast acquisition of whole-body post-therapy SPECT/CT is feasible with the new StarGuide system. Short scanning time improves the patients' clinical experience and compliance which may lead to increased adoption of post-therapy SPECT. This opens the possibility to offer imaged-based treatment response assessment and personalized dosimetry to patients referred for targeted radionuclide therapies.

Keyphrases

pet ct
end stage renal disease
computed tomography
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
positron emission tomography
stem cells
drug delivery
patient reported outcomes
contrast enhanced
bone marrow
patient reported
electron microscopy